Patents by Inventor Jayanthi Suryakumar

Jayanthi Suryakumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Extended release formulation of a direct thrombin inhibitor
    Patent number: 10016417
    Abstract: Extended release formulations of 3-fluoro-2-pyridylmethyl-3-(2,2-difluoro-2-(2-pyridyl)ethylamino)-6-chloropyrazin-2-one-1-acetamide (DPOC-4088) that provide for better control of blood plasma levels. The extended release formulations maintain substantially constant plasma levels of the active ingredient for at least about 16 hours and provide for once-daily dosing.
    Type: Grant
    Filed: November 6, 2012
    Date of Patent: July 10, 2018
    Assignee: Diakron Pharmaceuticals, Inc.
    Inventors: Sankar Ramakrishnan, Elumalal Venkatesan, Jayanthi Suryakumar, Stephane Allard
  • EXTENDED RELEASE FORMULATION OF A DIRECT THROMBIN INHIBITOR
    Publication number: 20140309239
    Abstract: Extended release formulations of 3-fluoro-2-pyridylmethyl-3-(2,2-difluoro-2-(2-pyridyl)ethylamino)-6-chloropyrazin-2-one-1-acetamide (DPOC-4088) that provide for better control of blood plasma levels. The extended release formulations maintain substantially constant plasma levels of the active ingredient for at least about 16 hours and provide for once-daily dosing.
    Type: Application
    Filed: November 6, 2012
    Publication date: October 16, 2014
    Applicant: Diakron Pharmaceuticals Inc.
    Inventors: Sankar Ramakrishnan, Elumalal Venkatesan, Jayanthi Suryakumar, Stephane Allard